Titre : Oxygénation hyperbare

Oxygénation hyperbare : Questions médicales fréquentes

Termes MeSH sélectionnés :

Gene Expression Profiling
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Oxygénation hyperbare : Questions médicales les plus fréquentes", "headline": "Oxygénation hyperbare : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Oxygénation hyperbare : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-26", "dateModified": "2025-04-20", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Oxygénation hyperbare" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Oxygénothérapie", "url": "https://questionsmedicales.fr/mesh/D010102", "about": { "@type": "MedicalCondition", "name": "Oxygénothérapie", "code": { "@type": "MedicalCode", "code": "D010102", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E02.880.690" } } }, "about": { "@type": "MedicalCondition", "name": "Oxygénation hyperbare", "alternateName": "Hyperbaric Oxygenation", "code": { "@type": "MedicalCode", "code": "D006931", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Richard E Moon", "url": "https://questionsmedicales.fr/author/Richard%20E%20Moon", "affiliation": { "@type": "Organization", "name": "Departments of Anesthesiology and Medicine, Center for Hyperbaric Medicine and Environmental Physiology, Duke University, North Carolina U.S." } }, { "@type": "Person", "name": "John P Kirby", "url": "https://questionsmedicales.fr/author/John%20P%20Kirby", "affiliation": { "@type": "Organization", "name": "John P. Kirby MD, FACS, is the Director of Wound Healing Programs, Associate Professor of Surgery, Section of Acute and Critical Care Surgery, at Washington University School of Medicine, Barnes-Jewish Hospital, in St. Louis, Missouri." } }, { "@type": "Person", "name": "Stephen R Thom", "url": "https://questionsmedicales.fr/author/Stephen%20R%20Thom", "affiliation": { "@type": "Organization", "name": "Emergency Medicine, University of Maryland, Baltimore, MD, USA." } }, { "@type": "Person", "name": "Michael H Bennett", "url": "https://questionsmedicales.fr/author/Michael%20H%20Bennett", "affiliation": { "@type": "Organization", "name": "Department of Diving and Hyperbaric Medicine, Prince of Wales Hospital and University of New South Wales, Sydney, New South Wales, Australia." } }, { "@type": "Person", "name": "Simon J Mitchell", "url": "https://questionsmedicales.fr/author/Simon%20J%20Mitchell", "affiliation": { "@type": "Organization", "name": "Department of Anaesthesiology, University of Auckland Faculty of Medicine, Auckland, New Zealand." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Genome-wide identification and expression profiling of sugar transporter genes in tobacco.", "datePublished": "2022-06-14", "url": "https://questionsmedicales.fr/article/35714802", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.gene.2022.146652" } }, { "@type": "ScholarlyArticle", "name": "Gene expression profiling of pancreatic ductal adenocarcinomas in response to neoadjuvant chemotherapy.", "datePublished": "2023-08-02", "url": "https://questionsmedicales.fr/article/37533202", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/cam4.6411" } }, { "@type": "ScholarlyArticle", "name": "The NeuroinflammatoryPotential of HIV-1 NefVariants in Modulating the Gene Expression Profile of Astrocytes.", "datePublished": "2022-10-17", "url": "https://questionsmedicales.fr/article/36291123", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/cells11203256" } }, { "@type": "ScholarlyArticle", "name": "Gene expression profiling of Group 3 medulloblastomas defines a clinically tractable stratification based on KIRREL2 expression.", "datePublished": "2022-06-30", "url": "https://questionsmedicales.fr/article/35771282", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00401-022-02460-1" } }, { "@type": "ScholarlyArticle", "name": "Genes deregulated in giant cell arteritis by Nanostring nCounter gene expression profiling in temporal artery biopsies.", "datePublished": "2024-09-24", "url": "https://questionsmedicales.fr/article/39317454", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/rmdopen-2024-004600" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Thérapeutique", "item": "https://questionsmedicales.fr/mesh/D013812" }, { "@type": "ListItem", "position": 3, "name": "Thérapie respiratoire", "item": "https://questionsmedicales.fr/mesh/D012138" }, { "@type": "ListItem", "position": 4, "name": "Oxygénothérapie", "item": "https://questionsmedicales.fr/mesh/D010102" }, { "@type": "ListItem", "position": 5, "name": "Oxygénation hyperbare", "item": "https://questionsmedicales.fr/mesh/D006931" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Oxygénation hyperbare - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Oxygénation hyperbare", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-16", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Oxygénation hyperbare", "description": "Comment diagnostiquer une décompression ?\nQuels tests pour l'oxygénation hyperbare ?\nQuels symptômes indiquent un traitement ?\nComment évaluer l'efficacité du traitement ?\nQuels critères pour l'admission en chambre hyperbare ?", "url": "https://questionsmedicales.fr/mesh/D006931?mesh_terms=Gene+Expression+Profiling&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Oxygénation hyperbare", "description": "Quels sont les symptômes de l'oxygénation hyperbare ?\nComment se manifeste l'intoxication à l'oxygène ?\nQuels signes d'une embolie gazeuse ?\nQuels symptômes après une séance d'oxygénation ?\nComment reconnaître une réaction allergique ?", "url": "https://questionsmedicales.fr/mesh/D006931?mesh_terms=Gene+Expression+Profiling&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Oxygénation hyperbare", "description": "Comment prévenir la maladie de décompression ?\nQuelles précautions avant une séance ?\nComment éviter l'intoxication à l'oxygène ?\nQuelles sont les recommandations post-traitement ?\nComment se préparer psychologiquement ?", "url": "https://questionsmedicales.fr/mesh/D006931?mesh_terms=Gene+Expression+Profiling&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Oxygénation hyperbare", "description": "Quelles conditions traitent l'oxygénation hyperbare ?\nComment se déroule une séance d'oxygénation ?\nQuelle est la durée d'une séance ?\nY a-t-il des effets secondaires ?\nQui peut administrer ce traitement ?", "url": "https://questionsmedicales.fr/mesh/D006931?mesh_terms=Gene+Expression+Profiling&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Oxygénation hyperbare", "description": "Quelles complications peuvent survenir ?\nComment gérer une embolie gazeuse ?\nQuels risques liés à l'oxygénation hyperbare ?\nComment prévenir les infections en chambre ?\nQuels signes d'une complication grave ?", "url": "https://questionsmedicales.fr/mesh/D006931?mesh_terms=Gene+Expression+Profiling&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Oxygénation hyperbare", "description": "Quels sont les facteurs de risque de décompression ?\nQui est à risque d'intoxication à l'oxygène ?\nQuels antécédents augmentent les risques ?\nComment l'âge influence-t-il les risques ?\nQuels médicaments augmentent les risques ?", "url": "https://questionsmedicales.fr/mesh/D006931?mesh_terms=Gene+Expression+Profiling&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une décompression ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic de décompression se fait par l'évaluation des symptômes et des antécédents d'immersion." } }, { "@type": "Question", "name": "Quels tests pour l'oxygénation hyperbare ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests d'imagerie et des évaluations cliniques sont utilisés pour déterminer l'indication." } }, { "@type": "Question", "name": "Quels symptômes indiquent un traitement ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme des douleurs articulaires, des troubles neurologiques ou des brûlures peuvent indiquer un traitement." } }, { "@type": "Question", "name": "Comment évaluer l'efficacité du traitement ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'efficacité est évaluée par l'amélioration des symptômes et des tests de suivi après traitement." } }, { "@type": "Question", "name": "Quels critères pour l'admission en chambre hyperbare ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les critères incluent des conditions médicales spécifiques et l'absence de contre-indications." } }, { "@type": "Question", "name": "Quels sont les symptômes de l'oxygénation hyperbare ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent inclure des douleurs, des vertiges, et des troubles de la vision." } }, { "@type": "Question", "name": "Comment se manifeste l'intoxication à l'oxygène ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "L'intoxication à l'oxygène se manifeste par des convulsions, des nausées et des troubles respiratoires." } }, { "@type": "Question", "name": "Quels signes d'une embolie gazeuse ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent des douleurs thoraciques, des difficultés respiratoires et des troubles neurologiques." } }, { "@type": "Question", "name": "Quels symptômes après une séance d'oxygénation ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Après une séance, des sensations de fatigue ou de légers maux de tête peuvent survenir." } }, { "@type": "Question", "name": "Comment reconnaître une réaction allergique ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Une réaction allergique peut se manifester par des éruptions cutanées, des démangeaisons ou un gonflement." } }, { "@type": "Question", "name": "Comment prévenir la maladie de décompression ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention inclut une ascension lente après la plongée et des pauses de sécurité." } }, { "@type": "Question", "name": "Quelles précautions avant une séance ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Évitez de fumer, de consommer de l'alcool et informez le médecin de vos antécédents médicaux." } }, { "@type": "Question", "name": "Comment éviter l'intoxication à l'oxygène ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Pour éviter l'intoxication, respectez les protocoles de traitement et les durées recommandées." } }, { "@type": "Question", "name": "Quelles sont les recommandations post-traitement ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Après traitement, reposez-vous et évitez les activités physiques intenses pendant 24 heures." } }, { "@type": "Question", "name": "Comment se préparer psychologiquement ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Préparez-vous en vous informant sur le traitement et en discutant avec des professionnels." } }, { "@type": "Question", "name": "Quelles conditions traitent l'oxygénation hyperbare ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Elle traite des conditions comme la maladie de décompression, les infections et les brûlures." } }, { "@type": "Question", "name": "Comment se déroule une séance d'oxygénation ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Une séance se déroule dans une chambre pressurisée où le patient respire de l'oxygène pur." } }, { "@type": "Question", "name": "Quelle est la durée d'une séance ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Une séance dure généralement entre 60 et 120 minutes, selon la condition traitée." } }, { "@type": "Question", "name": "Y a-t-il des effets secondaires ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires peuvent inclure des douleurs aux oreilles, des nausées ou des troubles visuels." } }, { "@type": "Question", "name": "Qui peut administrer ce traitement ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement doit être administré par des professionnels de santé formés en médecine hyperbare." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des lésions pulmonaires, des convulsions et des infections." } }, { "@type": "Question", "name": "Comment gérer une embolie gazeuse ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Une embolie gazeuse nécessite une intervention rapide, souvent avec une oxygénation hyperbare." } }, { "@type": "Question", "name": "Quels risques liés à l'oxygénation hyperbare ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les risques incluent des barotraumatismes, des troubles de la vision et des réactions allergiques." } }, { "@type": "Question", "name": "Comment prévenir les infections en chambre ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Pour prévenir les infections, maintenez une bonne hygiène et suivez les protocoles de désinfection." } }, { "@type": "Question", "name": "Quels signes d'une complication grave ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme des douleurs thoraciques intenses ou des troubles neurologiques nécessitent une attention immédiate." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque de décompression ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent la profondeur de plongée, la durée et l'absence de pauses de sécurité." } }, { "@type": "Question", "name": "Qui est à risque d'intoxication à l'oxygène ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Les plongeurs et les patients recevant une oxygénation hyperbare à haute pression sont à risque." } }, { "@type": "Question", "name": "Quels antécédents augmentent les risques ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Des antécédents de troubles respiratoires ou neurologiques peuvent augmenter les risques." } }, { "@type": "Question", "name": "Comment l'âge influence-t-il les risques ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes âgées peuvent avoir un risque accru de complications en raison de la fragilité des tissus." } }, { "@type": "Question", "name": "Quels médicaments augmentent les risques ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Certains médicaments, comme les diurétiques, peuvent augmenter le risque de déshydratation et de complications." } } ] } ] }

Sources (10000 au total)

Gene expression profiling of pancreatic ductal adenocarcinomas in response to neoadjuvant chemotherapy.

Pancreatic ductal adenocarcinoma (PDAC) has the lowest survival rate of all major cancers. Chemotherapy is the mainstay systemic therapy for PDAC, and chemoresistance is a major clinical problem leadi... Archived formalin-fixed paraffin-embedded tumor tissue samples from patients treated with neoadjuvant chemotherapy were obtained during surgical resection. Specimens were macrodissected and gene expre... Initially, unsupervised multivariate modeling was performed by principal component analysis, which demonstrated a distinct gene expression profile between good- and poor-chemotherapy responders. There... A distinct tumor biological profile between PDAC patients who either respond or not respond to chemotherapy was identified....

Genes deregulated in giant cell arteritis by Nanostring nCounter gene expression profiling in temporal artery biopsies.

To identify differentially expressed genes in temporal artery biopsies (TABs) from patients with giant cell arteritis (GCA) with different histological patterns of inflammation: transmural inflammatio... Expression of 770 immune-related genes was profiled with the NanoString nCounter PanCancer Immune Profiling Panel on formalin-fixed paraffin-embedded TABs from 42 GCA patients with TMI, 7 GCA patients... Unsupervised clustering of the samples revealed two distinct groups: normal TABs and TABs with ILA in one group, 41/42 TABs with TMI in the other one. TABs with TMI showed 31 downregulated and 256 upr... TABs with TMI had a distinct transcriptome compared with normal TABs and TABs with ILA. The few genes potentially deregulated in ILA were also deregulated in TMI. Gene profiling allowed to deepen the ...

Identification and Validation of Common Reference Genes for Normalization of Esophageal Squamous Cell Carcinoma Gene Expression Profiles.

Esophageal squamous cell carcinoma (ESCC) is one of the subtypes of esophageal cancer with Chinese characteristics, and its five-year survival rate is less than 20%. Early diagnosis is beneficial to i...

Identification and Validation of Autophagy-Related Genes in Primary Ovarian Insufficiency by Gene Expression Profile and Bioinformatic Analysis.

To investigate the relationship between primary ovarian insufficiency and autophagy, we detected and got the expression profile of human granulosa cell line SVOG, which was with or without LPS induced... Totally, 6 genes were selected as candidate hub genes which might correlate with the process of primary ovarian insufficiency. The expression of hub genes was then validated by quantitative real-time ... The results indicated that autophagy might play an essential role in the process and underlying molecular mechanism of primary ovarian insufficiency, which was revealed for the first time and may help...

Intralesional gene expression profile of JAK-STAT signaling pathway and associated cytokines in

The JAK-STAT signaling pathway is a central cascade of signal transduction for the myriad of cytokines in which dysregulation has been implicated in progression of inflammatory and infectious diseases... This study sought to investigate differential gene expression of several cytokines and their associated... Results showed that the gene expression levelsof both Th1 (... Our finding revealed dysregulation of cytokines and related...

Identification and gene expression profiling of human gonadotrophic pituitary adenoma stem cells.

Gonadotrophic pituitary adenoma is a major subtype of pituitary adenoma in the sellar region, but it is rarely involved in the hypersecretion of hormones into blood; thus, it is commonly regarded as "... The hPASCs from 14 human gonadotrophic pituitary adenoma clinical samples were cultured and verified via immunohistochemistry. Genetic profiling of hPASCs and the matched tumor cells was performed thr... The hPASCs were successfully isolated and cultured from gonadotrophic pituitary adenoma in vitro, which were identified as positive for generic stem cell markers (Sox2, Oct4, Nestin and CD133) via imm... Genetic profiling of hPASCs may explain the tumorigenesis and invasiveness of gonadotrophic pituitary adenoma. ANXA2 may serve as a potential therapeutic target for the treatment of gonadotrophic pitu...